Home › Graves Disease › Arizona
Graves Disease clinical trials in Arizona
5 studies for Graves Disease are looking for participants at sites in Arizona.
Cities in Arizona
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
- Site-044, Tucson
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 17, 2026 · NCT07661056A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
- Sun City Clinical Research, Glendale
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 4, 2026 · NCT07722546Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
- Site 112, Gilbert
- Site 130, Phoenix
- Clinical Research Site, Tucson
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07682896A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1015, Tucson
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 25, 2026 · NCT07018323A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1036, Phoenix
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 25, 2026 · NCT06727604From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.